Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
08/2002
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066445A1 Quinazoline derivatives
08/29/2002WO2002066444A1 6-(1-fluoroethyl)-5-iodo-4-aminopyrimidine compounds, process for preparation of the same, and pest controllers for agricultural and horticultural use
08/29/2002WO2002066443A2 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives
08/29/2002WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002WO2002066036A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
08/29/2002WO2002065979A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
08/29/2002WO2002026718A3 Bicyclic pyrimidin-4-one based inhibitors of factor xa
08/29/2002WO2002000622A3 Aminoalcohol derivatives
08/29/2002WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002WO2000010981A9 Quinazoline derivatives
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120168 Difluoromethyl ether derivative and process for producing the same
08/29/2002US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/29/2002US20020119979 Cancer therapy
08/29/2002US20020119960 Drug resistance therapy
08/29/2002US20020119910 Drug delivery
08/29/2002CA2442742A1 Quinazoline derivatives
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2438231A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
08/29/2002CA2434648A1 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
08/29/2002CA2434230A1 6-(1-fluoroethyl)-5-iodo-4-aminopyrimidine compounds, process for preparing the same, and agricultural and horticultural chemicals for controlling noxious organisms
08/29/2002CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists
08/29/2002CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/28/2002EP1234827A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234826A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234825A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234824A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234823A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
08/28/2002EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
08/28/2002EP1233949A2 5-substituted arylpyrimidines
08/28/2002EP1233948A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
08/28/2002EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
08/28/2002EP1119528B1 Chemical constructs and their uses
08/28/2002EP0856001B1 Pyrimidine derivatives as 5ht2c receptor antagonists
08/28/2002EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease
08/28/2002EP0531475B1 Naphthyl organic compounds
08/28/2002CN1366461A Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as active ingredient
08/28/2002CN1366460A Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient
08/28/2002CN1366459A Preventive or therapeutic drugs for various eosinophilia-realated diseases containing chymase inhibitors as active ingredient
08/27/2002US6441172 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
08/27/2002US6441171 Method for the production of 4,6-dichloropyrimidine with the aid of phosgene
08/27/2002US6441170 Method of producing 4,6-dichloropyrimidine with acid chlorides
08/27/2002US6441169 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
08/27/2002US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
08/27/2002US6440986 Viricides
08/27/2002US6440985 Methods for treating viral infections
08/27/2002US6440976 Iminopyrimidine NMDA NR2B receptor antagonists
08/27/2002US6440975 Amino acid derivatives, the preparation and use thereof as endothelin antagonists
08/27/2002US6440965 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
08/27/2002US6440618 Imaging element containing a blocked photographically useful compound
08/22/2002WO2002064572A1 Quinazolines as mmp-13 inhibitors
08/22/2002WO2002064571A1 Pyrimidine matrix metalloproteinase inhibitors
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064080A2 Matrix metalloproteinase inhibitors
08/22/2002WO2002063957A2 Selective substituted aryl ketone and safener based herbicides
08/22/2002WO2002042280A3 Pyrimidine derivatives
08/22/2002WO2002036587A3 Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
08/22/2002WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance
08/22/2002US20020115868 Novel process for making 5-substituted pyrazoles
08/22/2002US20020115858 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
08/22/2002US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects
08/22/2002US20020115724 Methods and agents for inhibiting protein aging
08/22/2002US20020115685 Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/22/2002US20020115674 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents
08/22/2002US20020115673 Preparation of risperidone
08/22/2002US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance
08/22/2002CA2437760A1 Selective substituted aryl ketone and safener based herbicides
08/22/2002CA2437643A1 Matrix metalloproteinase inhibitors
08/22/2002CA2437122A1 Quinazolines as mmp-13 inhibitors
08/21/2002EP1233013A1 Novel phenylalanine derivatives
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002EP1232146A1 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer
08/21/2002EP0900015B1 Fungicide salts
08/21/2002EP0683659B1 A method for stimulating hair growth with cationic derivatives of minoxidil using therapeutic iontophoresis
08/21/2002CN1365357A Trifluoromethyl pyri(mi) diene carboxamides
08/21/2002CN1089339C Preparation of 4,6-dimethoxy-2-((phenoxy carbonyl) amino) pyrimidine
08/21/2002CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages
08/20/2002US6437127 5,6-difluoro-4-phenoxypyrimidine reacts with methyl 1-methoxyimino-1-(2-oxocyclopentan-1-yl)-acetate to form methyl 1-methoxyimino-1-(2-(5-fluoro-6-phenoxy-pyrimid-4-yl)-penten-1-yl)-acetate
08/20/2002US6437126 Substituted phenyluracils
08/20/2002US6437118 Reacting 4-amino-1h-pyrmidin-2-one with vinyl borane in presence of palladium complex and base
08/20/2002US6436949 Heterocyclically substituted benzamides and their use
08/20/2002US6436945 Substituted O6-benzyl-8-aza-guanines
08/20/2002US6436943 Use of dihydropyrimidines as medicaments, and novel substances
08/20/2002US6436928 Selective neurokinin antagonists
08/20/2002US6436919 Local anesthetics that have longer duration of action while reducing undesired side effects
08/20/2002CA2240138C Quinazolin-4-one ampa antagonists
08/15/2002WO2002062799A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
08/15/2002WO2002062798A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
08/15/2002WO2002062768A1 Herbicidal sulfonylureas
08/15/2002WO2002062767A1 Novel quinazoline derivatives
08/15/2002WO2002062766A2 Melanocortin-4 receptor binding compounds and methods of use thereof
08/15/2002WO2002062762A2 Potassium channel openers
08/15/2002WO2002062750A1 Cannabinoid receptor ligands
08/15/2002WO2002062324A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
08/15/2002WO2002062301A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails